REQUEST A DEMO
Total
USD $0.00
Search more companies

AB Medis Ir Betonas (Lithuania)

Main Activities: Ready-Mix Concrete Manufacturing
Full name: AB Medis Ir Betonas Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

AB Medis Ir Betonas is based in Lithuania, with the head office in Naujoji Akmene. The enterprise operates in the Ready-Mix Concrete Manufacturing industry. The company was established on January 23, 1997. There are currently 56 (2025) people employed by AB Medis Ir Betonas. The latest financial highlights indicate a net sales revenue increase of 17.15% in 2023. AB Medis Ir Betonas’s net profit margin increased by 5.85% in 2023.

Headquarters
J. Dalinkeviciaus g. 2
Naujoji Akmene; Siauliai county; Postal Code: LT-85118

Contact Details: Purchase the AB Medis Ir Betonas report to view the information.

Basic Information
Total Employees:
Purchase the AB Medis Ir Betonas report to view the information.
Registered Capital:
Purchase the AB Medis Ir Betonas report to view the information.
Financial Auditors:
Purchase the AB Medis Ir Betonas report to view the information.
Incorporation Date:
January 23, 1997
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after AB Medis Ir Betonas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
17.15%
Total operating revenue
17.15%
Net Profit (Loss) for the Period
137.96%
Total Equity
91.09%
Net Profit Margin
5.85%
Return on Equity (ROE)
9.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?